ClinicalTrials.Veeva

Menu

Respiatory Viral Infections in Patients with Multiple Myeloma

U

University Medical Centre Ljubljana

Status

Completed

Conditions

Respiratory Viral Infections
Multiple Mieloma

Treatments

Other: Viral PCR test

Study type

Observational

Funder types

Other

Identifiers

NCT06810115
83/03/15

Details and patient eligibility

About

Respiratory viruses are known to be a major cause of morbodity in multiple myeloma patients but prospective long-term sudies are lacking. We analysed 219 multiple myeloma patients that had 554 nasopharingeal swabs with 58 documented viral episodes. Respiratory viruses studied were rhinovirus, enterovirus, parainflienza, respirator, syncytial virus, metapneumovirus, coronavirus, bocavirus, influenza A, influenza B. Clinical data were extracted from a prospectively entered database, medical records were reviewed. We have prospectively studiend patients until May 2019 when we gathered survival data. Lastly because of Covid-19 pandemic when almost no other viral infections were isolated, we analysed clinical course of respiratory infections in patients with multiple myeloma after the pandemic.

Enrollment

219 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patients with multiple myeloma

Exclusion Criteria:Other hematological malignancies

Trial design

219 participants in 1 patient group

Patient with multiple myeloma
Treatment:
Other: Viral PCR test

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems